VJOncology is committed to improving our service to you

ASCO 2020 | Targeted therapy in NSCLC at ASCO 2020

VJOncology is committed to improving our service to you

Riyaz Shah

Riyaz Shah, FRCP, PhD, Maidstone and Tunbridge Wells NHS Trust, Kent, UK, gives his thoughts on the data coming from the ADAURA study (NCT02511106) and other targeted therapies in the treatment of non-small cell lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter